Anti-PEDF antibody [EPR9826(B)]
- RabMAb
- Recombinant
- What is this?
Be the first to review this product! Submit a review
|
(5 Publications)
Rabbit Recombinant Monoclonal PEDF antibody. Suitable for WB and reacts with Human samples. Cited in 5 publications.
View Alternative Names
PEDF, PIG35, SERPINF1, Pigment epithelium-derived factor, Cell proliferation-inducing gene 35 protein, EPC-1, Serpin F1
- WB
Unknown
Western blot - Anti-PEDF antibody [EPR9826(B)] (AB157207)
All lanes:
Western blot - Anti-PEDF antibody [EPR9826(B)] (ab157207) at 1/1000 dilution
Lane 1:
Human plasma at 10 µg
Lane 2:
Human serum at 10 µg
Lane 3:
Y79 (Human retinoblastoma cell line) lysate at 10 µg
Lane 4:
A549 (Human lung carcinoma cell line) lysate at 10 µg
Lane 5:
HEK-293T (Human epithelial cell line from embryonic kidney transformed with large T antigen) lysate at 10 µg
Lane 6:
K562 (Human chronic myelogenous leukemia cell line from bone marrow) lysate at 10 µg
Predicted band size: 46 kDa
false
Related conjugates and formulations (1)
-
Anti-PEDF antibody [EPR9826(B)] - BSA and Azide free
Reactivity data
Product details
Species reactivity
Mouse, Rat: We have preliminary internal testing data to indicate this antibody may not react with these species.
Please contact us for more information.
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
PEDF plays a significant role in controlling angiogenesis due to its ability to inhibit excessive blood vessel formation. This makes PEDF essential in balancing the vasculature and nutrient availability in tissues. While PEDF does not form part of a larger protein complex its activity influences the biological interplay between cells by stabilizing the extracellular matrix and influencing cell signaling pathways involved in maintaining tissue homeostasis.
Pathways
PEDF interacts directly within the angiogenesis and neuroprotection pathways influencing cellular processes critical for normal tissue function. In angiogenesis PEDF disrupts the VEGF pathway by serving as an inhibitor thereby restricting uncontrolled vessel growth. It also plays a role in neuroprotection pathways where it cooperates with proteins like nerve growth factor to enhance neuronal survival and repair processes.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (5)
Recent publications for all applications. Explore the full list and refine your search
PloS one 17:e0279191 PubMed36574366
2022
Applications
Unspecified application
Species
Unspecified reactive species
International journal of molecular sciences 22: PubMed33810153
2021
Applications
Unspecified application
Species
Unspecified reactive species
Methods in molecular biology (Clifton, N.J.) 1994:31-39 PubMed31124102
2019
Applications
Unspecified application
Species
Unspecified reactive species
Nature 535:164-8 PubMed27383988
2016
Applications
Unspecified application
Species
Unspecified reactive species
Cancer biology & therapy 17:507-14 PubMed26987032
2016
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com